Marco Salvetti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience	NEUROTHERAPEUTICS	2024
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach	MULTIPLE SCLEROSIS	2024
Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report	NEUROLOGICAL SCIENCES	2024
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN)	NEUROLOGICAL SCIENCES	2024
Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease	FRONTIERS IN NEUROLOGY	2024
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study	JOURNAL OF NEUROLOGY	2024
EBV infection drives MS pathology: Yes	MULTIPLE SCLEROSIS	2024
Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization Analysis	MICROORGANISMS	2024
Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy	PATHOGENS	2024
Exploring miRNAs' based modeling approach for predicting PIRA in multiple sclerosis. A comprehensive analysis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
Long-Term Follow-Up before and during Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7	THE CEREBELLUM	2024
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program	MULTIPLE SCLEROSIS JOURNAL, EXPERIMENTAL, TRANSLATIONAL AND CLINICAL	2024
Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple Sclerosis	CURRENT NEUROPHARMACOLOGY	2024
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study	NEUROTHERAPEUTICS	2024
Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Sars-CoV2 infection in pregnant women with multiple sclerosis	MULTIPLE SCLEROSIS	2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?	EUROPEAN JOURNAL OF NEUROLOGY	2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observation	MULTIPLE SCLEROSIS AND RELATED DISORDERS	2023
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients	NEUROLOGICAL SCIENCES	2023

1
2
3
4
5
6
7
8
9
seguente ›
ultima »

Progetti di Ricerca

Laboratori di ricerca

Laboratori di Colture Cellulari 2